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necessary. It is a time consuming task and during this time 
the patient are treated with a suboptimal planor put on hold. 
Instead, a deformable registration can be made in an 
external software using MVCT scans from the Tomotherapy 
treatment as base to deform the original CT to be similar to 
the patients present anatomy. The structures are deformed 
with the CT and a new optimisation and QA can be made, the 
whole process can be ready until the next treatment. This 
deformed CT with plan can be used waiting for the new CT 
scan or replace it altogether.  
Materials and Methods: The first step was to verify the 
deformable registration. We used a third party software 
called InSimQA to deform a CT with structures which in turn 
was exported to our deformable registration software in 
Varian Eclipse to be deformed back. The difference in 
structure deformation was evaluated with Dice similarity 
index and volume difference. A Tomotherapy plan was also 
optimized on the CT deformed in InSimQA and the CT 
deformed back in Eclipse. The difference between the CT in 
Eclipse and the original CT, and CT from InSimQA against the 
original CT respectively, was evaluated. We used gamma 
index to compare the dose distributions. 
In the second step we used a patient previously treated with 
Tomotherapy, rescanned and reoptimised. The original CT 
was deformed with a MVCT as base. As a reference the 
original CT was deformed with the rescanned CT as base to 
compare delineation of structures between the rescanned CT 
and the original CT. A Tomotherapy plan was also optimised 
on the deformed CT and one on the rescanned CT and 
compared. We compared the plan optimised from the 
deformed CT but recalculated on the rescanned CT against 
the rescanned CT plan. We used gamma index to compare 
the dose distributions.  
 
 
Results: The result of our analysis is presented in table 1. For 
the Retrospective patient analysis we see a good agreement 
between target structures but not on parotis. That difference 
could be due to delineation differences since the agreement 
even to CT to CT deformation is Dice index of 0.75. Gamma 
analysis on dose show a good pass with 96.25% pass rate on 
the total body. 
Conclusions: The method is possible to use as a method for 
adaptive planning on Tomotherapy, even if further analysis is 
required. It is essential that a complete verification process 
for the deformable registration is in place. A recalculation of 
the new plan on an existing MVCT to verify dose distribution 
and important risk organs as medulla spinalis is prudent.  
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Purpose/Objective: Adaptive radiotherapy aims to adjust the 
treatment plan during the treatment course to ensure correct 
target coverage and to avoid normal tissue complications. 
The goal of this study was to investigate the effectiveness of 
an adaptive planning procedure incorporating offline dose 
feed-back to manage the entire treatment planning. To this 
purpose a retrospective analysis was performed on fifteen 
patients with prostatic tumor treated with IGRT-IMRT.  
Materials and Methods: A Siemens ArtisteTM was used for 
IGRT-IMRT treatments of the fifteen patients included in the 
study. Pinnacle3 Treatment Planning System (TPS) was used 
for the clinical practice while a beta version of Raysearch TPS 
was used retrospectively for the adaptive analysis. Quantec 
dose volume constraints were used for IMRT planning while 
for the PTV coverage V98%> 98%. The theoretical plan 
delivered to the patient, was re-calculated with Raysearch 
Station on the reference CT images. This plan was taken as 
the baseline of the treatment. The real dose delivered to the 
patient was calculated on the daily acquired CBCT and 
compared with the theoretical baseline. To track every 
treatment, the most significant cut off point for the rectum 
and for the bladder was identified for each patient, while for 
the PTV coverage V98% was considered. All the treatments 
were analyzed performing a track with the most 
representative CBCT of the weekly treatments; a total of 8/7 
CBCT were included in the recalculation. . 
Results: The PTV coverage of the delivered treatment 
recalculated on the daily CBCT not always satisfy the 
expected goal (V98%> 98%): 6 patients over 15 did not 
maintain at the end of the delivered treatment this desired 
percentage. The DVH cut off points for the bladder and the 
rectum resulting from the clinical optimization differ from 
those obtained with the real treatment delivered: one 
patient only over 15 failed for the bladder, while for the 
rectum all the patients respected the criteria at the end of 
the delivered treatment. 
Conclusions: The offline dose compensation technique in 
image guide radiation therapy can effectively consider the 
residual uncertainties which cannot be corrected online. The 
comparison of the cumulative dose with the approved 
treatment planning dose, resulted in a deviation of the 
accepted initial conditions of PTV coverage and OARs 
constraints in six over fifteen patients. For these patients a 
well-timed re-planning during the treatment would have 
avoided these discrepancies. This retrospective analysis 
suggests the need of correction strategies to improve the 
final treatment. 
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Purpose/Objective: In radiotherapy (RT) of urinary bladder 
cancer, variations in the shape, size and position of the 
bladder is a major challenge. Our institutions are therefore 
running a clinical ART daily plan selection trial for bladder 
cancer where the bladder every day is treated with the 
smallest possible PTV. Since the trial also includes patients 
who will receive elective lymph node irradiation, we are 
treating patients based on bony anatomy registration 
although set-up based on soft tissue (i.e. bladder) 
registration might be favourable. Still the increased patient 
awareness of the importance of having an empty bladder at 
each treatment session might reduce the difference between 
soft tissue vs. bony anatomy based registrations. In this study 
we are therefore comparing the difference between these 
two registration strategies for patients treated within vs. 
outside the adaptive protocol.  
Materials and Methods: This study included both the first ten 
patients from our institution included in the bladder ART trial 
(treated from December 2013) as well as the nine last 
patients treated before enrolling patients in the trial. The 
difference between bony anatomy vs soft tissue registration 
was compared between these two groups using weekly CBCTs 
for all patients. For the bony anatomy registration, the 
patients were aligned on the whole pelvic bones excluding 
the moveable part of the femoral heads. The soft tissue 
match on the bladder the registration volume was narrowed 
to approximately 1 cm from the bladder-CTV. The difference 
between the registration strategies was assessed by 
calculating the vector length of the difference from Cartesian 
coordinates. 
Results: Patients treated within the ART trial have a much 
stronger association between soft tissue and bony anatomy 
registration. Of the 10 patients treated with ART none had a 
vector length of the difference between the strategies larger 
than 2 mm. Conversely, for the 9 patients treated without 
ART only one patient had a vector length below 2 mm. The 
standard deviations of the vector length for all ART patients 
were around 1 mm while it ranged between 1 mm and 3 mm 
for the non-ART patients. The mean vector length of the 
difference was 1.5 mm for the ART patients and 3.8 mm for 
the non-ART patients the difference in the vector is 
statistical significant with a p-value of 0.0006. The vertical 
difference were statistical significant with a p-value of 
0.0044 while the longitudinal and lateral differences had a p-
value of 0.4128 respectively 0.9105 
Conclusions: For patients treated with ART the difference 
between a bony anatomy and a soft tissue registration is in 
the order of 2 mm compared to 4 mm for bladder patients 
treated before enrolment in the ART protocol. This 
difference is possibly due to the increased patient-awareness 
to the bladder emptying instruction. This awareness also 
minimize the changes of the bladder during treatment 
leading to a smaller volume irradiated. 
